These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 26497049)
1. Discovery of 1,1'-Biphenyl-4-sulfonamides as a New Class of Potent and Selective Carbonic Anhydrase XIV Inhibitors. La Regina G; Coluccia A; Famiglini V; Pelliccia S; Monti L; Vullo D; Nuti E; Alterio V; De Simone G; Monti SM; Pan P; Parkkila S; Supuran CT; Rossello A; Silvestri R J Med Chem; 2015 Nov; 58(21):8564-72. PubMed ID: 26497049 [TBL] [Abstract][Full Text] [Related]
2. Benzenesulfonamide bearing 1,2,4-triazole scaffolds as potent inhibitors of tumor associated carbonic anhydrase isoforms hCA IX and hCA XII. SitaRam ; Celik G; Khloya P; Vullo D; Supuran CT; Sharma PK Bioorg Med Chem; 2014 Mar; 22(6):1873-82. PubMed ID: 24560737 [TBL] [Abstract][Full Text] [Related]
3. Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies. Gitto R; Agnello S; Ferro S; De Luca L; Vullo D; Brynda J; Mader P; Supuran CT; Chimirri A J Med Chem; 2010 Mar; 53(6):2401-8. PubMed ID: 20170095 [TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase inhibitors. Synthesis of a novel series of 5-substituted 2,4-dichlorobenzenesulfonamides and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII. Sławiński J; Pogorzelska A; Żołnowska B; Brożewicz K; Vullo D; Supuran CT Eur J Med Chem; 2014 Jul; 82():47-55. PubMed ID: 24871996 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of a new series of N⁴-substituted 4-(2-aminoethyl)benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII. Sławiński J; Brzozowski Z; Żołnowska B; Szafrański K; Pogorzelska A; Vullo D; Supuran CT Eur J Med Chem; 2014 Sep; 84():59-67. PubMed ID: 25016228 [TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms. Buemi MR; De Luca L; Ferro S; Bruno E; Ceruso M; Supuran CT; Pospíšilová K; Brynda J; Řezáčová P; Gitto R Eur J Med Chem; 2015 Sep; 102():223-32. PubMed ID: 26276436 [TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides. Nishimori I; Vullo D; Innocenti A; Scozzafava A; Mastrolorenzo A; Supuran CT Bioorg Med Chem Lett; 2005 Sep; 15(17):3828-33. PubMed ID: 16039848 [TBL] [Abstract][Full Text] [Related]
8. Flow synthesis and biological activity of aryl sulfonamides as selective carbonic anhydrase IX and XII inhibitors. Rosatelli E; Carotti A; Ceruso M; Supuran CT; Gioiello A Bioorg Med Chem Lett; 2014 Aug; 24(15):3422-5. PubMed ID: 24948563 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of N-(5-methyl-isoxazol-3-yl/1,3,4-thiadiazol-2-yl)-4-(3-substitutedphenylureido) benzenesulfonamides as human carbonic anhydrase isoenzymes I, II, VII and XII inhibitors. Mishra CB; Kumari S; Angeli A; Monti SM; Buonanno M; Prakash A; Tiwari M; Supuran CT J Enzyme Inhib Med Chem; 2016; 31(sup2):174-179. PubMed ID: 27314170 [TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII. Sławiński J; Szafrański K; Vullo D; Supuran CT Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761 [TBL] [Abstract][Full Text] [Related]
11. Amido/ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII. Eldehna WM; Fares M; Ceruso M; Ghabbour HA; Abou-Seri SM; Abdel-Aziz HA; Abou El Ella DA; Supuran CT Eur J Med Chem; 2016 Mar; 110():259-66. PubMed ID: 26840366 [TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors. Synthesis, molecular structures, and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with novel 3-pyridinesulfonamide derivatives. Brzozowski Z; Sławiński J; Gdaniec M; Innocenti A; Supuran CT Eur J Med Chem; 2011 Sep; 46(9):4403-10. PubMed ID: 21820216 [TBL] [Abstract][Full Text] [Related]
15. Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies. Carta F; Garaj V; Maresca A; Wagner J; Avvaru BS; Robbins AH; Scozzafava A; McKenna R; Supuran CT Bioorg Med Chem; 2011 May; 19(10):3105-19. PubMed ID: 21515057 [TBL] [Abstract][Full Text] [Related]
16. Anticonvulsant 4-aminobenzenesulfonamide derivatives with branched-alkylamide moieties: X-ray crystallography and inhibition studies of human carbonic anhydrase isoforms I, II, VII, and XIV. Hen N; Bialer M; Yagen B; Maresca A; Aggarwal M; Robbins AH; McKenna R; Scozzafava A; Supuran CT J Med Chem; 2011 Jun; 54(11):3977-81. PubMed ID: 21506569 [TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors. Regioselective synthesis of novel series 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII. Brzozowski Z; Sławiński J; Vullo D; Supuran CT Eur J Med Chem; 2012 Oct; 56():282-91. PubMed ID: 22910138 [TBL] [Abstract][Full Text] [Related]
19. Kinetic and X-ray crystallographic investigations on carbonic anhydrase isoforms I, II, IX and XII of a thioureido analog of SLC-0111. Lomelino CL; Mahon BP; McKenna R; Carta F; Supuran CT Bioorg Med Chem; 2016 Mar; 24(5):976-81. PubMed ID: 26810836 [TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase inhibitors: synthesis and inhibition studies against mammalian isoforms I-XV with a series of 2-(hydrazinocarbonyl)-3-substituted-phenyl-1H-indole-5-sulfonamides. Güzel O; Innocenti A; Scozzafava A; Salman A; Parkkila S; Hilvo M; Supuran CT Bioorg Med Chem; 2008 Oct; 16(20):9113-20. PubMed ID: 18819811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]